Corona Vaccine: Indigenous mRNA vaccine approved for emergency use

Pune based company Genova Biopharma has developed this vaccine

The first indigenous mRNA vaccine of Corona developed in India has been approved by the Drug Controller General of India (DCGI) for emergency use. The vaccine has been developed by Pune-based company Genova Biopharma. It will be given to people 18 years of age and above. The GEMCOVAC-19 vaccine is being touted as a gamechanger for the healthcare industry. In addition, the Drug Controller General of India has also approved the Covavex Covid-19 vaccine manufactured by Serum Institute, which will be administered to children aged 7 to 11 years.

A meeting of the Subject Expert Committee (SEC) on Friday recommended emergency use of mRNA vaccine to deal with corona, which has now been approved by India’s drug regulator late Tuesday night. Last month, Genoa issued a statement regarding its Phase-3 trial of the vaccine. It was told that during the Phase-2 and Phase-3 trials, the vaccine has been tested on 4000 people. While the rest of the mRNA vaccine has to be stored at a temperature below zero, this Genoa vaccine will not spoil even if kept at 2-8 °C. This will make it very easy to carry. Genoa CEO Dr Sanjay Singh said that two doses of the vaccine have been approved. This dose will be given at an interval of 28 days.

According to a report, messenger RNA is a type of RNA that is essential for the production of proteins in the body. The mRNA provides the blueprint for how proteins are made inside cells. For this he uses the information of the gene. Once cells make proteins, they quickly break down mRNA. The mRNA of the vaccine does not enter the nucleus of the cells and does not change the DNA.

(function (d, s, id) {
var js, fjs = d.getElementsByTagName(s)[0];
if (d.getElementById(id))
js = d.createElement(s); = id;
fjs.parentNode.insertBefore(js, fjs);
}(document, ‘script’, ‘facebook-jssdk’));

Back to top button